DiBiase Mary

CIK 00018801791 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001880179

Recent Transactions

25 trades

Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2025-02-12+650,000→ 1,140,980 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2025-01-24$0.45/sh−22,258→ 490,980 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2025-01-23+61,178→ 513,238 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2024-10-07$0.57/sh−67,695→ 452,060 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2024-10-04+230,645→ 519,755 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2024-09-09$0.66/sh−2,642→ 289,110 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2024-03-11$0.88/sh−15,409→ 291,752 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Appreciation Right
2024-02-13+428,248→ 428,248 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2024-02-12$1.01/sh−3,683→ 307,161 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-11-01$0.73/sh−67,695→ 310,844 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-10-31+230,645→ 378,539 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-09-08$1.25/sh−2,642→ 147,894 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-06-30$1.89/sh−464→ 150,536 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-06-23$1.93/sh−857→ 151,000 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-06-15$2.23/sh−857→ 151,857 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-03-10$0.84/sh−18,192→ 152,714 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-02-13$0.93/sh−4,348→ 170,906 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Appreciation Right
2022-11-07+1,350,000→ 1,350,000 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-08-17−1,713→ 177,896 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-06-30−1,578→ 179,609 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-06-24−856→ 181,187 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-06-16−856→ 182,043 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-03-01+105,000→ 182,899 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-02-11−12,545→ 77,899 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-09-08+27,000→ 90,444 total

Companies

X4 Pharmaceuticals, Inc
Chief Operating Officer
$XFOR

Recent Filings

Address

C/O X4 PHARMACEUTICALS, INC. 61 NORTH BEACON STREET 4TH FLOOR

BOSTON, MA, 02134

View on SEC.gov